Displaying 1 - 50 of 149 results
Released Company Title Industry Topic
06 May 2024
15:05 CEST
THOR MEDICAL ASA Primary insider trading 20103010 Biotechnology Mandatory notification of trade primary insiders
02 May 2024
13:59 CEST
THOR MEDICAL ASA New share capital registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Apr 2024
17:00 CEST
THOR MEDICAL ASA Share option grant 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Apr 2024
12:20 CEST
THOR MEDICAL ASA Grant of restricted stock units (RSU) to the members of the board 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Apr 2024
12:17 CEST
THOR MEDICAL ASA Issuance of shares to members of the board 20103010 Biotechnology Mandatory notification of trade primary insiders
11 Apr 2024
21:07 CEST
THOR MEDICAL ASA Minutes from the annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
11 Apr 2024
14:45 CEST
THOR MEDICAL ASA Completion of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
10 Apr 2024
16:30 CEST
THOR MEDICAL ASA Business update from CEO in relation to the company's AGM 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Apr 2024
17:21 CEST
THOR MEDICAL ASA Flagging Thor Medical ASA 08.04.2024 20103010 Biotechnology Major shareholding notifications
03 Apr 2024
21:12 CEST
THOR MEDICAL ASA Thor Medical ASA – Mottatte stemmefullmakter til ordinær generalforsamling 2024 20103010 Biotechnology Flagging
03 Apr 2024
21:08 CEST
THOR MEDICAL ASA Thor Medical ASA - Mottatte stemmefullmakter til ordinær generalforsamling 2024 20103010 Biotechnology Flagging
02 Apr 2024
15:52 CEST
THOR MEDICAL ASA Flagging Thor Medical ASA 02.04.2024 20103010 Biotechnology Flagging
21 Mar 2024
09:19 CET
THOR MEDICAL ASA Thor Medical ASA - Notice of Annual General Meeting on 11 April 2024 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
21 Mar 2024
07:00 CET
THOR MEDICAL ASA Thor Medical publishes Annual Report 2023 20103010 Biotechnology Annual financial and audit Reports
14 Mar 2024
08:17 CET
THOR MEDICAL ASA Thor Medical ASA receives Innovation Norway grant for lab and pilot facilities at Herøya 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Mar 2024
07:30 CET
THOR MEDICAL ASA THOR MEDICAL ASA EMPLOYS BREDE ELLINGSÆTER AS CFO 20103010 Biotechnology Mandatory notification of trade primary insiders
28 Feb 2024
07:00 CET
THOR MEDICAL ASA Thor Medical ASA reports 2023 results - current focus on establishing pilot plant 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
21 Feb 2024
08:03 CET
THOR MEDICAL ASA Invitation to presentation of Thor Medical ASA's second half results 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Feb 2024
07:30 CET
THOR MEDICAL ASA THOR MEDICAL EMPLOYS JASPER KURTH AS NEW CEO 20103010 Biotechnology Inside information
19 Jan 2024
16:27 CET
THOR MEDICAL ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Dec 2023
12:40 CET
THOR MEDICAL ASA Thor Medical ASA builds lab and pilot facilities at Herøya as key milestones towards industrial-scale production of alpha emitters 20103010 Biotechnology Non-regulatory press releases
30 Nov 2023
20:06 CET
THOR MEDICAL ASA Thor Medical signs agreement to transfer its Nordic Nanovector patents to NucliThera 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
15 Nov 2023
08:30 CET
THOR MEDICAL ASA Thor Medical ASA signs LOI for offtake with US and Scandinavian based clinical trial stage companies 20103010 Biotechnology Non-regulatory press releases
31 Oct 2023
16:45 CET
THOR MEDICAL ASA Thor Medical ASA expands expertise and positions for growth with two experienced chemistry professionals 20103010 Biotechnology Non-regulatory press releases
31 Aug 2023
07:00 CEST
THOR MEDICAL ASA Thor Medical ASA first half 2023 results 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
17 Aug 2023
15:39 CEST
THOR MEDICAL ASA Invitation to presentation of Thor Medical ASA's first half results 2023 20103010 Biotechnology Non-regulatory press releases
05 Jul 2023
10:45 CEST
NORDIC NANOVECTOR Thor Medical – New share capital and name registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
04 Jul 2023
07:54 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
03 Jul 2023
21:34 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA: Notification of transactions by close associates of primary insiders 20103010 Biotechnology Mandatory notification of trade primary insiders
03 Jul 2023
18:08 CEST
NORDIC NANOVECTOR The acquisition of Thor Medical AS is completed 20103010 Biotechnology Inside information
03 Jul 2023
16:11 CEST
NORDIC NANOVECTOR Nordic Nanovector – Issuance of shares to former board members and restricted stock units (RSU) to current board members 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
29 Jun 2023
11:47 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
29 Jun 2023
11:46 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
29 Jun 2023
11:45 CEST
NORDIC NANOVECTOR Nordic Nanovector ASA – Disclosure of large shareholding 20103010 Biotechnology Major shareholding notifications
28 Jun 2023
16:45 CEST
NORDIC NANOVECTOR Nordic Nanovector - Appointment of Alf Bjørseth as CEO 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
28 Jun 2023
16:30 CEST
NORDIC NANOVECTOR Nordic Nanovector - Completion of annual general meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Jun 2023
14:26 CEST
NORDIC NANOVECTOR NANOV AGM - Disclosure of proxies 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Jun 2023
14:10 CEST
NORDIC NANOVECTOR NANOV AGM - Publication of Exempted Document 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Jun 2023
16:27 CEST
NORDIC NANOVECTOR NANOV - Endring i forslag til vedtak 14 på GF 28.juni 2023 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
22 Jun 2023
14:36 CEST
NORDIC NANOVECTOR Jostein Dahle, Chief Scientific Officer and Co-Founder, leaves the Company 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
22 Jun 2023
14:36 CEST
NORDIC NANOVECTOR Jostein Dahle forlater Nordic Nanovector 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
15 Jun 2023
13:13 CEST
NORDIC NANOVECTOR Nordic Nanovector - GF vedlegg 20103010 Biotechnology Årsrapporter og revisjonsberetninger
15 Jun 2023
13:13 CEST
NORDIC NANOVECTOR Nordic Nanovector - AGM attachments 20103010 Biotechnology Annual financial and audit Reports
07 Jun 2023
14:46 CEST
NORDIC NANOVECTOR Nordic Nanovector - Mandatory notification of trade - primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jun 2023
14:30 CEST
NORDIC NANOVECTOR Nordic Nanovector - Notice of Annual General Meeting on 28 June 2023 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
07 Jun 2023
13:44 CEST
NORDIC NANOVECTOR The Chairman of the Board buys shares in Nordic Nanovector 20103010 Biotechnology Mandatory notification of trade primary insiders
07 Jun 2023
13:44 CEST
NORDIC NANOVECTOR Styreleder kjøper aksjer i Nordic Nanovector 20103010 Biotechnology Meldepliktig handel for primærinnsidere
06 Jun 2023
20:37 CEST
NORDIC NANOVECTOR NANOV announces agreement to acquire Thor Medical 20103010 Biotechnology Innsideinformasjon
06 Jun 2023
20:10 CEST
NORDIC NANOVECTOR Nordic Nanovector announces agreement to acquire Thor Medical, an emerging producer of alpha-emitters for radiopharmaceuticals to treat cancer 20103010 Biotechnology Inside information
18 Apr 2023
11:15 CEST
NORDIC NANOVECTOR Nordic Nanovector Publishes Data from the PARADIGME Phase 2 Clinical Trials with Betalutin® on European Clinical Trials Database 20103010 Biotechnology Non-regulatory press releases